Contrast Media/Contrast Agents Market by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022

Table of Contents

1 INTRODUCTION 17

1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20

2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Key industry insights 24
2.2 MARKET SIZE ESTIMATION 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 RESEARCH ASSUMPTIONS 29

3 EXECUTIVE SUMMARY 30

3.1 INTRODUCTION 30

4 PREMIUM INSIGHTS 35

4.1 CONTRAST MEDIA/CONTRAST AGENTS: MARKET OVERVIEW 35
4.2 ASIA PACIFIC CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE 36
4.3 GEOGRAPHIC SNAPSHOT: CONTRAST MEDIA/CONTRAST AGENTS MARKET 37
4.4 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS, BY INDICATION 38
4.5 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY 38

5 MARKET OVERVIEW 39

5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Increasing number of public & private diagnostic centers 40
5.2.1.2 Large number of approvals for contrast agents 40
5.2.2 RESTRAINTS 41
5.2.2.1 Side effects and allergic reactions associated with contrast agents 41
5.2.3 OPPORTUNITIES 42
5.2.3.1 Entry of generic contrast media products 42
5.2.3.2 Increasing research activities for contrast agents 42
5.2.4 CHALLENGES 44
5.2.4.1 Technological advancements in imaging solutions 44
5.2.4.2 Restriction and withdrawal of linear gadolinium-based contrast agents 44

6 PIPELINE ASSESSMENT 45

6.1 INTRODUCTION 45
6.2 CLINICAL TRAILS USING CONTRAST MEDIA 45
6.3 PRODUCT PIPELINE 49

7 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE 52

7.1 INTRODUCTION 53
7.2 IODINATED CONTRAST MEDIA 54
7.3 GADOLINIUM-BASED CONTRAST MEDIA 55
7.4 MICROBUBBLE CONTRAST MEDIA 56
7.5 BARIUM-BASED CONTRAST MEDIA 57

8 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY 59

8.1 INTRODUCTION 60
8.2 X-RAY/CT 61
8.3 MAGNETIC RESONANCE IMAGING 62
8.4 ULTRASOUND 63

9 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION 65

9.1 INTRODUCTION 66
9.2 CARDIOVASCULAR DISORDERS 67
9.3 CANCER 68
9.4 GASTROINTESTINAL DISORDERS 69
9.5 MUSCULOSKELETAL DISORDERS 70
9.6 NEUROLOGICAL DISORDERS 71
9.7 NEPHROLOGICAL DISORDERS 72

10 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION 74

10.1 INTRODUCTION 75
10.2 INTRAVASCULAR 76
10.3 ORAL 77
10.4 RECTAL 78
10.5 OTHER ROUTES 78
 

11 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION 80

11.1 INTRODUCTION 81
11.2 RADIOLOGY 82
11.3 INTERVENTIONAL RADIOLOGY 83
11.4 INTERVENTIONAL CARDIOLOGY 84

12 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION 85

12.1 INTRODUCTION 86
12.2 NORTH AMERICA 87
12.2.1 US 90
12.2.2 CANADA 94
12.3 EUROPE 98
12.3.1 GERMANY 103
12.3.2 UK 106
12.3.3 FRANCE 109
12.3.4 ROE 112
12.4 ASIA PACIFIC 115
12.4.1 CHINA 119
12.4.2 JAPAN 122
12.4.3 INDIA 124
12.4.4 ROAPAC 127
12.5 REST OF THE WORLD 130

13 COMPETITIVE LANDSCAPE 136

13.1 OVERVIEW 136
13.2 MARKET SHARE ANALYSIS 136
13.3 COMPETITIVE SCENARIO 139
13.3.1 MARKET DEVELOPMENTS (REGULATORY AND PRODUCT APPROVALS) 139
13.3.2 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS 140
13.3.3 EXPANSIONS 141
13.3.4 MERGERS AND ACQUISITIONS 142
13.3.5 OTHER STRATEGIES 142

14 COMPANY PROFILES 143

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
14.1 GE HEALTHCARE 143
14.2 BAYER 146
14.3 BRACCO IMAGING 149
14.4 GUERBET 152
14.5 LANTHEUS 156
14.6 DAIICHI SANKYO 158
14.7 UNIJULES LIFE SCIENCES 160
14.8 SPAGO NANOMEDICAL 161
14.9 J.B. CHEMICALS AND PHARMACEUTICALS 163
14.10 MAGNUS HEALTH 165
14.11 TAEJOON PHARM 166
14.12 JODAS 167
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
15 APPENDIX 168

LIST OF TABLES

TABLE 1 INDICATIVE LIST OF RESEARCH STUDIES UNDERTAKEN BY RESEARCH INSTITUTES AND UNIVERSITIES 43
TABLE 2 INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED FOR CONTRAST MEDIA/ CONTRAST AGENTS 47
TABLE 3 INDICATIVE LIST OF THE PRODUCT PIPELINE FOR CONTRAST MEDIA/CONTRAST AGENTS 49
TABLE 4 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 53
TABLE 5 IODINATED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION,
2015–2022 (USD MILLION) 55
TABLE 6 GADOLINIUM-BASED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015–2022 (USD MILLION) 56
TABLE 7 MICROBUBBLE CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015–2022 (USD MILLION) 57
TABLE 8 BARIUM-BASED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 9 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 60
TABLE 10 X-RAY/CT CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION,
2015–2022 (USD MILLION) 61
TABLE 11 MRI CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION,
2015–2022 (USD MILLION) 62
TABLE 12 ULTRASOUND CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015–2022 (USD MILLION) 64
TABLE 13 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 66
TABLE 14 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2015–2022 (USD MILLION) 67
TABLE 15 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR CANCER, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 16 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2015–2022 (USD MILLION) 70
TABLE 17 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 18 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2015–2022 (USD MILLION) 72
TABLE 19 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2015–2022 (USD MILLION) 73
TABLE 20 CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 75
TABLE 21 INTRAVASCULAR CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015–2022 (USD MILLION) 76
TABLE 22 ORAL CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION,
2015–2022 (USD MILLION) 77
TABLE 23 RECTAL CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION,
2015–2022 (USD MILLION) 78
TABLE 24 OTHER CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION,
2015–2022 (USD MILLION) 79
TABLE 25 CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 81
TABLE 26 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR RADIOLOGY, BY REGION, 2015–2022 (USD MILLION) 82
TABLE 27 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2015–2022 (USD MILLION) 83
TABLE 28 CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2015–2022 (USD MILLION) 84
TABLE 29 NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 88
TABLE 30 NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015–2022 (USD MILLION) 88
TABLE 31 NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 88
TABLE 32 NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 89
TABLE 33 NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET,
BY INDICATION, 2015–2022 (USD MILLION) 89
TABLE 34 NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET,
BY APPLICATION, 2015–2022 (USD MILLION) 90
TABLE 35 US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 91
TABLE 36 US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 92
TABLE 37 US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 92
TABLE 38 US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 93
TABLE 39 US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 93
TABLE 40 INDICATIVE LIST OF RESEARCH PROJECTS IN CANADA, 2014–2017 95
TABLE 41 CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 96
TABLE 42 CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 96
TABLE 43 CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 97
TABLE 44 CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 97
TABLE 45 CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 98
TABLE 46 EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 100
TABLE 47 EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 100
TABLE 48 EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 101
TABLE 49 EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 101
TABLE 50 EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 102
TABLE 51 EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 102
TABLE 52 GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015–2022 (USD MILLION) 103
TABLE 53 GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 104
TABLE 54 GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 104
TABLE 55 GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 105
TABLE 56 GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 105
TABLE 57 UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY ,
2015–2022 (USD MILLION) 107
TABLE 58 UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 107
TABLE 59 UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 108
TABLE 60 UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 108
TABLE 61 UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 109
TABLE 62 FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 110
TABLE 63 FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 110
TABLE 64 FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 111
TABLE 65 FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 111
TABLE 66 FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 112
TABLE 67 ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 112
TABLE 68 ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 113
TABLE 69 ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 113
TABLE 70 ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION
2015–2022 (USD MILLION) 114
TABLE 71 ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 114
TABLE 72 ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 116
TABLE 73 APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY ,
2015–2022 (USD MILLION) 116
TABLE 74 APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 117
TABLE 75 APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 117
TABLE 76 APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION
2015–2022 (USD MILLION) 118
TABLE 77 APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 118
TABLE 78 CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY ,
2015–2022 (USD MILLION) 119
TABLE 79 CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 120
TABLE 80 CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 120
TABLE 81 CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION
2015–2022 (USD MILLION) 121
TABLE 82 CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 121
TABLE 83 JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 122
TABLE 84 JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 122
TABLE 85 JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 123
TABLE 86 JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION
2015–2022 (USD MILLION) 123
TABLE 87 JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 124
TABLE 88 INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 125
TABLE 89 INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 125
TABLE 90 INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 126
TABLE 91 INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION
2015–2022 (USD MILLION) 126
TABLE 92 APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 127
TABLE 93 ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 128
TABLE 94 ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 128
TABLE 95 ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 129
TABLE 96 ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION
2015–2022 (USD MILLION) 129
TABLE 97 ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 130
TABLE 98 ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY,
2015–2022 (USD MILLION) 133
TABLE 99 ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE,
2015-2022 (USD MILLION) 133
TABLE 100 ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015–2022 (USD MILLION) 134
TABLE 101 ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION
2015–2022 (USD MILLION) 134
TABLE 102 ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 135
TABLE 103 MARKET DEVELOPMENTS (REGULATORY AND PRODUCT APPROVALS) 139
TABLE 104 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS 140
TABLE 105 EXPANSIONS 141
TABLE 106 MERGERS AND ACQUISITIONS 142
TABLE 107 OTHER STRATEGIES 142

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: GLOBAL CONTRAST MEDIA/CONTRAST
AGENTS MARKET 20
FIGURE 2 RESEARCH DESIGN 21
FIGURE 3 KEY DATA FROM PRIMARY SOURCES 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 25
FIGURE 5 SAMPLING FRAME: PRIMARY RESEARCH 25
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 26
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 8 DATA TRIANGULATION METHODOLOGY 28
FIGURE 9 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY (2017) 30
FIGURE 10 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017 VS. 2022 31
FIGURE 11 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017 VS. 2022 31
FIGURE 12 CONTRAST MEDIA/CONTRAST AGENTS MARKET ANALYSIS, BY APPLICATION,
2017 VS. 2022 32
FIGURE 13 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017 VS. 2022 32
FIGURE 14 ASIA PACIFIC IS SLATED TO WITNESS THE HIGHEST GROWTH IN THE CONTRAST MEDIA/CONTRAST AGENTS MARKET DURING THE FORECAST PERIOD 33
FIGURE 15 NORTH AMERICA TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 35
FIGURE 16 JAPAN TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CONTRAST MEDIA/CONTRAST AGENTS MARKET (2017) 36
FIGURE 17 CHINA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 37
FIGURE 18 CARDIOVASCULAR DISORDERS TO COMMAND THE LARGEST MARKET SHARE IN 2017 AND 2022 38
FIGURE 19 X-RAY/CT TO COMMAND THE LARGEST MARKET SHARE IN 2017 38
FIGURE 20 CONTRAST MEDIA/CONTRAST AGENTS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39
FIGURE 21 CLINICAL TRIALS FOR CONTRAST MEDIA/CONTRAST AGENTS,
BY PHASE (2014 ONWARDS) 45
FIGURE 22 CLINICAL TRIALS FOR CONTRAST MEDIA/CONTRAST AGENTS, BY INDICATION (2014 ONWARDS) 46
FIGURE 23 MICROBUBBLE CONTRAST MEDIA/CONTRAST AGENTS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 53
FIGURE 24 ULTRASOUND TO REGISTER HIGHEST CAGR DURING THE FORECAST PERIOD 60
FIGURE 25 CARDIOVASCULAR DISORDERS TO DOMINATE THE CONTRAST MEDIA/CONTRAST AGENTS MARKET IN 2017 66
FIGURE 26 INTRAVASCULAR ROUTE OF ADMINISTRATION, THE FASTEST-GROWING SEGMENT IN THE CONTRAST MEDIA /CONTRAST AGENTS MARKET 75
FIGURE 27 RADIOLOGY IS EXPECTED TO BE THE LARGEST APPLICATION SEGMENT IN THE CONTRAST MEDIA /CONTRAST AGENTS MARKET IN 2017 81
FIGURE 28 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST MEDIA /CONTRAST AGENTS MARKET IN 2017 86
FIGURE 29 NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT 87
FIGURE 30 PREVALENCE OF ALZHEIMER'S IN THE US, BY AGE GROUP, 2015 91
FIGURE 31 EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT 99
FIGURE 32 ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT 115
FIGURE 33 ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT 132
FIGURE 34 GLOBAL CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2016 136
FIGURE 35 KEY DEVELOPMENTS OF THE PROMINENT PLAYERS IN THE CONTRAST MEDIA /CONTRAST AGENTS MARKET (2014-2017) 138
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT 143
FIGURE 37 BAYER: COMPANY SNAPSHOT 146
FIGURE 38 GUERBET GROUP: COMPANY SNAPSHOT 152
FIGURE 39 LANTHEUS: COMPANY SNAPSHOT 156
FIGURE 40 DAIICHI SANKYO: COMPANY SNAPSHOT 158
FIGURE 41 SPAGO NANOMEDICAL: COMPANY SNAPSHOT 161
FIGURE 42 J.B. CHEMICALS AND PHARMACEUTICALS: COMPANY SNAPSHOT 163

当レポートのプレスリリースは発行されておりません。